TW200516153A - Human toll-like receptor 3 gene polymorphism as marker for inherited factor of allergic disease and utilization of the same - Google Patents

Human toll-like receptor 3 gene polymorphism as marker for inherited factor of allergic disease and utilization of the same

Info

Publication number
TW200516153A
TW200516153A TW093129861A TW93129861A TW200516153A TW 200516153 A TW200516153 A TW 200516153A TW 093129861 A TW093129861 A TW 093129861A TW 93129861 A TW93129861 A TW 93129861A TW 200516153 A TW200516153 A TW 200516153A
Authority
TW
Taiwan
Prior art keywords
receptor
marker
utilization
allergic disease
same
Prior art date
Application number
TW093129861A
Other languages
English (en)
Inventor
Kazuhiko Obara
Yusuke Nakamura
Mayumi Tamari
Original Assignee
Hitachi Chemical Co Ltd
Riken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Chemical Co Ltd, Riken filed Critical Hitachi Chemical Co Ltd
Publication of TW200516153A publication Critical patent/TW200516153A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW093129861A 2003-10-03 2004-10-01 Human toll-like receptor 3 gene polymorphism as marker for inherited factor of allergic disease and utilization of the same TW200516153A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003346191 2003-10-03

Publications (1)

Publication Number Publication Date
TW200516153A true TW200516153A (en) 2005-05-16

Family

ID=34419497

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093129861A TW200516153A (en) 2003-10-03 2004-10-01 Human toll-like receptor 3 gene polymorphism as marker for inherited factor of allergic disease and utilization of the same

Country Status (3)

Country Link
JP (1) JP4533979B2 (zh)
TW (1) TW200516153A (zh)
WO (1) WO2005033339A1 (zh)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2289912C (en) * 1997-05-07 2011-07-26 Schering Corporation Human receptor proteins; related reagents and methods
US6740487B1 (en) * 1999-06-10 2004-05-25 University Of Iowa Research Foundation Variant TLR4 nucleic acid and uses thereof
AU2002362138A1 (en) * 2001-12-11 2003-06-23 Eva Lorenz Toll-like receptor 4 mutations

Also Published As

Publication number Publication date
JP4533979B2 (ja) 2010-09-01
WO2005033339A1 (ja) 2005-04-14
JPWO2005033339A1 (ja) 2007-11-15

Similar Documents

Publication Publication Date Title
CY1105212T1 (el) Αντισωματα αντι-april και κυτταρα υβριδωματος
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
ATE402188T1 (de) Bindungsproteine als biosensoren
DK1842226T3 (da) Homogen analytpåvisning
SG142154A1 (en) Methods for genomic analysis
WO2005067391A3 (en) Diagnostic test for parkinson's disease
BRPI0410289A (pt) ligantes do receptor de canabinóides e suas utilizações
DK1730315T3 (da) Polymorphismer i NOD2/Card15 gen
AU2003293141A1 (en) Methods for identifying risk of breast cancer and treatments thereof
WO2004078035A3 (en) Expression profiles for breast cancer and methods of use
ATE374838T1 (de) Nukleotidsequenzvariation im gen ns5a als marker
BRPI0412110A (pt) genes regulados no cáncer ovariano como alvos prognósticos e terapêuticos
EP1987165A4 (en) Gene with influence on the human memory
WO2003054166A3 (en) Nucleotide polymorphisms associated with osteoarthritis
WO2003105773A3 (en) MUTATIONS OF PDGFRA ACTIVATED AS DIAGNOSTIC MARKERS AND THERAPEUTIC TARGETS
TW200516153A (en) Human toll-like receptor 3 gene polymorphism as marker for inherited factor of allergic disease and utilization of the same
WO2000058510A3 (en) Schizophrenia associated genes, proteins and biallelic markers
AU2904197A (en) Diagnostic method and apparatus based on polymorphism in an IL-6 gene
DE602004027086D1 (de) Klassifizierung von kolonkrebs
WO2006006853A3 (en) Differences in intestinal gene expression profiles
TW200514850A (en) Method of evaluating risk for viral infection
EA200600012A1 (ru) Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку
Chessari et al. AT-IAP, a dual cIAP1 and XIAP antagonist with oral antitumor activity in melanoma models
AU2003301503A1 (en) Methods and compositions for assaying mutations in nucleic acids
PT1537210E (pt) Inibicao de oliconucleotidos decoy de expressao cd-40